BRCA1 and cancer: The increased risk of breast cancer in ATM carriers was then confirmed by direct ATM sequencing in breast cancer cases compared to controls [10] and ATM is now considered a moderate-penetrance cancer susceptibility gene in BRCA1/2-negative patients with familial early-onset breast cancer [11].